Drugs and thyroid

Journal of Association of Physicians of India

Volumn 55, Issue MAR., 2007, Pages 215-223

  George, Joe ^a   Joshi, Shashank R ^a  

^a KEM HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

CHEMICALLY INDUCED DISORDER; HUMAN; HYPOTHYROIDISM; REVIEW; THYROTOXICOSIS;

HUMANS; HYPOTHYROIDISM; PHARMACEUTICAL PREPARATIONS; THYROTOXICOSIS;

EID: 34247522744     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Surks MI, Siewert R. Drugs and Thyroid Function. NEJM 1995;333:1688-94.
2. Meier CA, Burger AC. Effects of drugs and other substances on thyroid hormone synthesis and metabolism. In Braverman LE, Utiger RD ed. Werner and Ingbar's the thyroid: a fundamental and clinical text. Lippincott Williams and Wilkins. 2005;229-46.
3. Reiffel JA, Estes III NA, Waldo AL, Prystowsky EN, Di Bianco R. A consensus report on antiarrhythmic drug use. Clin Cardiol 1994;17:103-16.
4. Vorperian VR, Havighurst TC, Miller S, January CT. Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 1997;30:791-8.
5. Holt DW, Tucker GT, Jackson PR, Storey GCA. Amiodarone pharmacokinetics. Am Heart J 1983;106:843-47.
6. Basaria S, Cooper DS. Amiodarone and the thyroid. The American J Medicine 2005;118:706-14.
7. Martino E, Safran M, Aghini-Lombardi F, Rajatanavin R, Lenziardi M, Fay M, Pacchiarotti A, Aronin A, Macchia E, Haffajee C, Baschieri L, Pinchera A, Braverman LE. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med 1984;101:28-34
8. Martino E, Aghini-Lombardi F, Mariotti S, Bartalena L, Braverman L, Pinchera A. Amiodarone: a common source of iodine induced thyrotoxicosis. Horm Res 1987;26:158-71.
9. Martino E, Aghini-Lombardi F, Mariotti S, Bartalena L, Lenziardi M, Ceccarelli C, Bambini G, Safran M, Braverman LE, Pinchera A. Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases. Clin Endocrinol (Oxf) 1987;26:227-37.
10. Harjai KJ, Licata AA. Effects of amiodarone on thyroid function. Ann Intern Med 1997;126:63-73.
11. Lombardi A, Martino E, Braverman LE. Amiodarone and the thyroid. Thyroid Today 1990;13:1-7.
12. Newnham HH, Topliss DJ, Legrand BA, Chosich N, Harper RW, Stockigt JR. Amiodarone-induced hyperthyroidism: assessment of the predictive value of biochemical testing and response to combined therapy with propylthiouracil and perchlorate. Aust NZ J Med 1988;18:37-44.
13. Trip MD, Wiersinga WM, Plomp TA. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med1991;91:507-11.
14. Albert SG, Alves LE, Rose EP. Thyroid dysfunction during chronic amiodarone therapy. J Am Coll Cardiol 1987;9:175-83.
15. Harjai KJ, Licata AA. Amiodarone-induced hyperthyroidism: a case series and brief review of literature. Pacing Clin Electrophysiol 1996;19:1548-54.
16. Keidar S, Grenadier E, Palant A. Amiodarone-induced thyrotoxicosis: four cases and a review of the literature. Postgrad J Med 1980;56:356-58.
17. Bartalena L, Grasso L, Bragioni S, et al. Serum interleukin-6 in Amiodarone induced thyrotoxicosis. J Clin Endocrinol Metab 1994;78:423-27.
18. Martino. E, Bartalena L, Bogazzi F, Braverman LE. The Effects of Amiodarone on the Thyroid. Endocrine Reviews 2001;22:240-54.
19. Wolff J. Perchlorate and the thyroid gland. Pharmacol Rev 1998;50:89-105.
20. Dickstein G, Shechner C, Adawi F, Kaplan J, Baron E, Ish-Shalom S. Lithium treatment in amiodarone-induced thyrotoxicosis. Am J Med 1997;102:454-58.
21. Bartalena L, Brogioni S, Grasso L, Bogazzi F, Burelli A, Martino E. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J Clin Endocrinol Metab 1996;81:2930-33.
22. Wiersinga WM. Amiodarone and the thyroid. In: Weetman AP, Grossman A. (eds) Pharmacotherapeutics of the Thyroid Gland. Springer Verlag, Berlin, 1997;225-87.
23. Erdogan MF, Gulec S, Tutar E, et al. A stepwise approach to the treatment of amiodarone induced thyrotoxicosis. Thyroid 2003;13:205.
24. Braverman LE, Ingbar SH, Vagenakis AG, Adams L, Maaloof F. Enhanced susceptibility to iodide myxedema in patients with Hashimoto's disease. J Clin Endocrinol Metab 1971;32:515-21.
25. Figge J, Dluhy RG. Amiodarone-induced elevation of thyroid stimulating hormone in patients receiving levothyroxine for primary hypothyroidism. Ann Intern Med 1990;113:553-55.
26. Baudin E, Marcellin P, Pouteau M, et al. Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin Endocrinol (Oxf) 1993;39:657-61.
27. Kung AWC, Jones BM, Lai CL. Effects of interferon-gamma therapy on thyroid function, T-lymphocyte subpopulations and induction of autoantibodies. J Clin Endocrinol Metab 1990;71:1230-4.
28. Vassilopoulou-Sellin R, Sella A, Dexeus FH, Theriault RL, Pololoff DA. Acute thyroid dysfunction (thyroiditis) after therapy with interleukin-2. Horm Metab Res 1992;24:434-8.
29. Lazarus JH. The effects of lithium therapy on thyroid and thyrotropin releasing hormone. Thyroid 1998;8:909-913.
30. Kirov.G. Thyroid disorders in Lithium treated patients. J Affect Disorders 1998;50:33-40.
31. Bocchetta A, Bernardi F, Pedditzi M, et al. Thyroid abnormalities during lithium treatment. Acta Psychiatr Scand 1991;83:193-8.
32. Miller KK, Daniels GH. Association between lithium use and thyrotoxicosis caused by silent thyroiditis. Clin Endocrinol (Oxf) 2001;55:501-08.
33. Stratakis CA, Chrousos GP. Transient elevation of serum thyroid hormone levels following Lithium discontinuation. Eur J Pediatrics 1996;155:939-41.
34. Larsen PR. Salicylate-induced increases in free triiodothyronine in human serum: evidence of inhibition of triiodothyronine binding to thyroxine-binding globulin and thyroxine-binding prealbumin. J Clin Invest 1972;51:1125-34.
35. Stockigt JR, Lim CF, Barlow JW, et al. Interaction of furosemide with serum thyroxine binding sites: in vivo and in vitro studies and comparison with other inhibitors. J Clin Endocrinol Metab 1985;60:1025-31.
36. Mendel CM, Frost PH, Kunitake ST, Cavalieri RR. Mechanism of the heparin induced increase in the concentration of free thyroxine in plasma. J Clin Endocrinol Metab 1987;65:1259-64.
37. Smith PJ, Surks MI. Multiple effects of diphenylhydantoin on the thyroid hormone system. Endocr Rev 1984;5:514-24.
38. Kristensen BO, Weeke J. Propranolol-induced increments in total and free serum thyroxine in patients with essential hypertension. Clin Pharmacol Ther 1977;22:864-7.
39. Murchison LE, How J, Bewsher PD. Comparison of propranolol and metoprolol in the management of hyperthyroidism. Br J Clin Pharmacol 1979;8:581-87.
40. Wilber JF, Utiger RD. The effect of glucocorticoids on thyrotropin secretion. J Clin Invest 1969;48:2086-90.
41. Chopra IJ, Williams DE, Orgiazzi J, Solomon DH. Opposite effects of dexamethasone on serum concentrations of 3,3′5′triiodothyronine (reverse T3) and 3,3_5-triiodothyronine (T3). J Clin Endocrinol Metab 1975;41:911-20.
42. Knopp RH, Bergelin RO, Wahl PW, Walden CE, Chapman MB. Clinical chemistry alterations in pregnancy and oral contraceptive use. Obstet Gynecol 1985;66:682-90.